A novel metastatic tumor segmentation method with a new evaluation metric in clinic study

Bin Li1, Qiushi Sun2, Xianjin Fang3

  • 1Department of Neurology, The First Hospital of Anhui University of Science and Technology, Huainan, China.

Frontiers in Medicine
|October 17, 2024
PubMed
Abstract

Insights

A new method, DRAU-Net, improves brain metastasis segmentation using novel attention mechanisms. This advancement aids radiologists in precise diagnosis and treatment planning for brain malignancies.

Area of Science:

  • Medical Imaging
  • Artificial Intelligence
  • Oncology

Background:

  • Brain metastases represent the most frequent brain malignancies.
  • Accurate segmentation of these lesions is crucial for radiological assessment and treatment planning.

Purpose of the Study:

  • To address limitations in current brain metastasis segmentation, particularly for small lesions.
  • To introduce an improved segmentation method and a novel evaluation metric for enhanced clinical utility.

Main Methods:

  • Proposed DRAU-Net, incorporating a multi-branch weighted attention module and DResConv module for complete tumor boundary extraction.
  • Introduced a multi-objective segmentation integrity metric for evaluating segmentation quality and target count, especially for small metastases.

Main Results:

  • DRAU-Net achieved a Dice coefficient of 0.6858 and a multi-objective segmentation integrity metric of 0.5582 on the BraTS2023 dataset and clinical data.
  • The proposed method demonstrated superior performance compared to existing techniques in segmenting metastatic tumors.

Conclusions:

  • DRAU-Net offers a significant advancement in brain metastasis segmentation accuracy.
  • The novel evaluation metric provides a more comprehensive assessment of segmentation performance for small, multiple lesions.

Related Concept Videos